Pauling Chu

Pauling Chu

Auto-generated profile, based on publicly available information

Pauling Chu

Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2003 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PCPauling Chu
Pauling Chu
TCTsu-Yi Chao
Tsu-Yi Chao
YLYuh-Feng Lin
Yuh-Feng Lin
AJAnthony J Janckila
Anthony J Janckila
LYLung T Yam
Lung T Yam

1 December 2003 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PDF file
KLKuo-Cheng Lu
Kuo-Cheng Lu
LYLai-King Yeung
Lai-King Yeung
SLShih-Hua Lin
Shih-Hua Lin
YLYuh-Feng Lin
Yuh-Feng Lin
PCPauling Chu
Pauling Chu

10 July 2014 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
MTMin-Hua Tseng
Min-Hua Tseng
CCChih-Jen Cheng
Chih-Jen Cheng
CSChih-Chien Sung
Chih-Chien Sung
YCYu-Ching Chou
Yu-Ching Chou
PCPauling Chu
Pauling Chu
SLShih-Hua Lin
Shih-Hua Lin
Hyponatremia is known to be a marker of poor prognosis in many clinical conditions. The association between hyponatremia and clinical outcomes in peritoneal dialysis-related peritonitis (PDRP) has not been studied. We evaluated the association between hyponatremia and clinical parameters of patients with PDRP.

1 February 2012 in Clinical Nephrology
Verified
Journal Article
Closed access
CWChih-Chiang Wang
Chih-Chiang Wang
YHYu-Juei Hsu
Yu-Juei Hsu
Chia-Chao WuChia-Chao Wu
Chia-Chao Wu
SYSung-Sen Yang
Sung-Sen Yang
GCGiien-Shuen Chen
Giien-Shuen Chen
PCPauling Chu
Pauling Chu
Both fetuin-A and hyperparathyroidism play crucial roles in vascular calcification (VC) and bone metabolism. However, the correlation between secondary hyperparathyroidism (SHPT), parathyroidectomy (PTX) and fetuin-A levels in dialysis patients has not yet been studied. For this study, we included 27 consecutive dialysis patients with severe SHPT who underwent total PTX with autotransplantation over a period of 2 years (from Oct 2006 to Sep 2008). Serum ionized calcium (iCa), phosphorus (Pi), bone-specific alkaline phosphatase (bAP), intact parathyroid hormone (iPTH), and fetuin-A were checked basally and 2, 7, 14, 30, and 60 days after PTX. Two days after PTX, the iPTH, serum iCa, and Pi concentrations significantly decreased. Serum bAP levels gradually increased after PTX, peaked after 14 days (p < 0.05), and then gradually decreased. Serum fetuin-A levels significantly increased during the first 7 days after PTX, peaked 14 days after PTX (0.21 ± 0.05 vs. 0.35 ± 0.07 mg/ml, p < 0.05), and then remained at a stable level 60 days after PTX. There were significant correlations between percentage increase in serum fetuin-A levels and percentage decrease in serum iPTH levels 2 days and 7 days after PTX (r = 0.526, p < 0.01; r = 0.403, p < 0.05, respectively) and correlations between percentage increase in serum fetuin-A levels and percentage decrease in serum iCa levels 30 and 60 days after PTX (r = 0.449, p < 0.05; r = 0.474, p < 0.05, respectively). Serum fetuin-A significantly increased after PTX in uremic patients with SHPT. The percentage increase in serum fetuin-A after PTX was closely correlated with the percentage decrease in serum iPTH levels immediately after PTX, and with the percentage decrease in serum iCa levels in the later stage after PTX. Further investigations are necessary to further understand the regulation of fetuin-A in dialysis patients with sSHPT.

1 September 1998 in ASAIO Journal
Verified
Journal Article
Closed access
GWGuo-Liang Wann
Guo-Liang Wann
YCYueh-Chung Chen
Yueh-Chung Chen
SLShih-Hua Lin
Shih-Hua Lin
WHWoei-Der Huang
Woei-Der Huang
PCPauling Chu
Pauling Chu
YLYuh-Feng Lin
Yuh-Feng Lin
Dry weight evaluation is generally made from clinical observation of body weight (BW) changes, edema, blood pressure, and chest radiograph. In fact, 25–50% of patients on chronic hemodialysis had an incorrectly determined dry weight. To predict dry weight, twenty stable patients on regular hemodialysis were enrolled to investigate the correlation among dry weight, hematocrit, blood volume (BV), and vasoactive hormones including plasma renin activity (PRA), aldosterone (PA), and cyclic 3',5'-guanosine monophosphate (cGMP) values. BV was estimated by an infrared light reflection method. PRA, PA, and plasma cGMP were determined by commercial radioimmunoassay kits. The results showed significantly decreasing plasma cGMP values toward the end of hemodialysis compared with before hemodialysis (15.76 ± 3.56 pmol/ml vs 33.57 ± 3.98 pmol/ml; p < 0.05). A significant correlation exists between changes in plasma cGMP values and BV (p < 0.05). In addition, no significant correlation exists between changes in plasma cGMP and BW. A good correlation was found between changes in BV and hematocrit throughout dialysis (r = −0.774; p < 0.001). PRA and PA values predict neither BV nor BW changes. All patients were treated to attain a further ultrafiltration of 0.5 to 1.0 L after reaching dry weight, and we found that the critical point in blood pressure drop occurred when BV decreased by 8% or when plasma cGMP values decreased by 50% from their initial values. Continuous BV monitoring with infrared light reflection and detecting of cGMP throughout hemodialysis could help predict dry weight and avoid dialysis hypotension.

1 November 2004 in The Lancet
Verified
Journal Article
Closed access
CCChih-Jen Cheng
Chih-Jen Cheng
PCPauling Chu
Pauling Chu
GHGuo-Shu Huang
Guo-Shu Huang
SLShih-Hua Lin
Shih-Hua Lin